Arvind Remedies shines on reporting 11% rise in Q1 net profit

21 Aug 2012 Evaluate

Arvind Remedies is currently trading at Rs. 25.51, up by 0.40 points or 1.62% from its previous closing of Rs. 24.75 on the BSE.

The scrip opened at Rs. 24.05 and has touched a high and low of Rs. 25.30 and Rs. 24.05 respectively. So far 37,000 shares were traded on the counter.

The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 26.35 on 08-Jun-2012 and a 52 week low of Rs. 18.00 on 15-Dec-2011.

Last one week high and low of the scrip stood at Rs. 25.75 and Rs. 24.00 respectively. The current market cap of the company is Rs. 121 crore.

The promoters holding in the company stood at 47.26% while Non-Institutions held 52.74% respectively.

On standalone basis, the company has reported a rises of 10.68% in its net profit at Rs 9.12 crore for the quarter, as compared to Rs 8.24 crore for the same quarter in the previous year. Total income of the company has increased by 29.98% to Rs 139.72 crore for the quarter under review as compared to Rs 107.49 crore for the quarter ended June 30, 2011.

Arvind Remedies is engaged in manufacturing of pharmaceutical formulations such as tablets, capsules (including soft gels), ointments and liquids. It has a manufacturing facility at Kakkalur in Tamil Nadu.

Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×